We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$371M
AUM Growth
+$28.6M
Cap. Flow
+$2.59M
Cap. Flow %
0.7%
Top 10 Hldgs %
20.99%
Holding
294
New
53
Increased
80
Reduced
104
Closed
57

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$4.02M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.92M
3
ORCL icon
Oracle
ORCL
+$2.07M
4
META icon
Meta Platforms (Facebook)
META
+$2.07M
5
HPE icon
Hewlett Packard
HPE
+$2.04M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.54M
2
AMAT icon
Applied Materials
AMAT
+$3.2M
3
AMGN icon
Amgen
AMGN
+$2.84M
4
APH icon
Amphenol
APH
+$2.24M
5
CRWD icon
CrowdStrike
CRWD
+$2.2M

Sector Composition

Rank Sector Weight
1 Technology 25.35%
2 Financials 15.35%
3 Healthcare 12.96%
4 Consumer Discretionary 9.56%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
176
Coca-Cola
KO
$375B
$471K 0.13%
6,557
-17,926
-73% -$1.23M
ANF icon
177
Abercrombie & Fitch
ANF
$5B
$468K 0.13%
3,346
+22
+0.7% +$3.35K
JLL icon
178
Jones Lang LaSalle
JLL
$16.7B
$460K 0.12%
+1,706
New +$414K
PEP icon
179
PepsiCo
PEP
$190B
$459K 0.12%
2,698
-50
-2% -$8.59K
CRM icon
180
Salesforce
CRM
$158B
$444K 0.12%
1,622
-45
-3% -$11.5K
LOW icon
181
Lowe's Companies
LOW
$125B
$444K 0.12%
1,638
-27
-2% -$6.54K
GS icon
182
Goldman Sachs
GS
$303B
$425K 0.11%
859
-13
-1% -$6.36K
ASPN icon
183
Aspen Aerogels
ASPN
$518M
$422K 0.11%
+15,257
New +$382K
ALNY icon
184
Alnylam Pharmaceuticals
ALNY
$29.3B
$416K 0.11%
+1,513
New +$394K
PFE icon
185
Pfizer
PFE
$153B
$402K 0.11%
13,880
-5,254
-27% -$153K
AMD icon
186
Advanced Micro Devices
AMD
$789B
$395K 0.11%
2,408
-105
-4% -$16K
LIN icon
187
Linde
LIN
$226B
$395K 0.11%
829
+157
+23% +$71.6K
CI icon
188
Cigna
CI
$74.6B
$392K 0.11%
1,130
-12
-1% -$4.13K
TMO icon
189
Thermo Fisher Scientific
TMO
$220B
$391K 0.11%
632
-25
-4% -$14.8K
ACN icon
190
Accenture
ACN
$108B
$391K 0.11%
1,105
-3,593
-76% -$1.18M
CAVA icon
191
CAVA Group
CAVA
$7.27B
$388K 0.1%
3,133
+894
+40% +$90.9K
AXP icon
192
American Express
AXP
$230B
$370K 0.1%
1,366
-3,892
-74% -$969K
ADBE icon
193
Adobe
ADBE
$105B
$370K 0.1%
714
+15
+2% +$8.23K
MCD icon
194
McDonald's
MCD
$195B
$357K 0.1%
1,173
-31
-3% -$8.54K
ELV icon
195
Elevance Health
ELV
$85.5B
$353K 0.1%
678
-9
-1% -$4.81K
HCA icon
196
HCA Healthcare
HCA
$89.5B
$346K 0.09%
851
-41
-5% -$15K
MCK icon
197
McKesson
MCK
$101B
$339K 0.09%
685
-2,036
-75% -$1.13M
ABT icon
198
Abbott
ABT
$187B
$333K 0.09%
2,920
-100
-3% -$11K
SPOT icon
199
Spotify
SPOT
$100B
$329K 0.09%
894
-2,996
-77% -$996K
AMAT icon
200
Applied Materials
AMAT
$428B
$318K 0.09%
1,573
-15,585
-91% -$3.2M
6 7
8
9 10

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Convergence Investment Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Convergence Investment Partners held 294 positions worth $371M, up 8.4% from $342M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2024 filing shows 53 new, 80 increased, 104 reduced and 57 closed positions. Its largest new stake was Bristol-Myers Squibb: 83,605 shares worth $4.33M. The largest sale was Microsoft, an estimated $4.54M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.

  • Convergence Investment Partners's largest Q3 2024 buy was Bristol-Myers Squibb: 83,605 shares worth $4.33M.
  • Convergence Investment Partners added most to Broadcom in Q3 2024, an estimated $4.02M increase.
  • Convergence Investment Partners's biggest Q3 2024 reduction was Microsoft, cutting an estimated $4.54M.
  • Convergence Investment Partners fully exited CrowdStrike in Q3 2024, selling an estimated $2.2M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $371M portfolio in Q3 2024.
  • Convergence Investment Partners opened 53 new positions and closed 57 in Q3 2024.
  • Convergence Investment Partners's portfolio value rose 8.4% quarter-over-quarter to $371M.

Based on Convergence Investment Partners's 13F filing for Q3 2024, filed 29 Oct 2024.